NCT05168501View on ClinicalTrials.gov

Assessing Variability of the Ventilatory Response to Duffin's Rebreathing Procedure

NACompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

December 27, 2021

Primary Completion Date

February 18, 2022

Study Completion Date

February 18, 2022

Conditions
VentilationReproducibilityPhysiology
Interventions
OTHER

Rebreathing procedure

Paired Duffin's rebreathing procedures performed two different isoxic end tidal PO2 levels (i.e., hyperoxic and hypoxic conditions) will be performed on Day 1 at 0, 2, 4, 6, and 24 hours.

Trial Locations (1)

53095

Spaulding Clinical Research, West Bend

All Listed Sponsors
collaborator

Spaulding Clinical Research LLC

OTHER

lead

Food and Drug Administration (FDA)

FED

NCT05168501 - Assessing Variability of the Ventilatory Response to Duffin's Rebreathing Procedure | Biotech Hunter | Biotech Hunter